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Abstract
Background Outcome of Helicobacter pylori (H. pylori)
infection results from interaction of multiple variables
including host, environmental and bacterial-associated
virulence factors.
Aim This study aimed to investigate the correlation of
cagA, cagE, vacA, iceA and babA2 genotypes with gastric
histopathology and disease phenotype in the central region
of a South-European country.
Methods This prospective study involved 148 infected
patients (110 female; mean age 43.5 ± 13.4 years) sub-
mitted to endoscopy with corpus and antrum biopsies. H.
pylori was cultured and DNA extracted from the isolates.
Genotypes were determined by PCR. Histopathological
features were graded according to the updated Sydney
system and OLGA/OLGIM classification. Only patients
with single H. pylori genotypes and complete histopa-
thological results were included.
Results Antrum samples presented higher degrees of
atrophy, intestinal metaplasia, chronic inflammation and
neutrophil activity. Genotype distribution was as follows:
cagA-31.8 %; cagE-45.9 %; vacA s1a-24.3 %; vacA s1b-
19.6 %; vacA s1c-0.7 %; vacA s2-55.4 %; vacA m1-
20.9 %; vacA m2-79.1 %; vacA s1m1-18.9 %; vacA s1m2-
25.7 %; vacA s2m1-2 %; vacA s2m2-53.4 %; iceA1-
33.8 %; iceA2-66.2 %; babA2-12.2 %. CagA genotype was
significantly associated with higher degrees of intestinal
metaplasia, neutrophil activity, chronic inflammation and
OLGIM stages. BabA2 was linked with higher H. pylori
density. Strains with vacA s1m1 or vacA s1m1 ? cagA
positive genotypes had a significant association with peptic
ulcer and vacA s2m2 with iron-deficient anemia.
Conclusions cagA, vacA s1m1 and babA2 genotypes are
relatively rare in the central region of Portugal. cagA-
positive strains are correlated with more severe histopa-
thological modifications. This gene is commonly associated
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with vacA s1m1, and such isolates are frequently found in
patients with peptic ulcer.
Keywords Helicobacter pylori  Genotype  Gastritis 
Histopathology  cagA  vacA
Introduction
Helicobacter pylori (H. pylori) infection affects an esti-
mated 50 % of the global population [1]. It is associated
with multiple gastric pathologies, including gastritis, gas-
troduodenal ulcer disease, gastric adenocarcinoma and
mucosa-associated lymphoid tissue (MALT) lymphoma
[2]. Approximately, 84.2 % of Portuguese adults are
infected by H. pylori [3]. However, there is not a direct
correlation between the prevalence of infection and the
prevalence of H. pylori related manifestations since only
approximately 10–20 % of those infected develop clinical
disease. This occurs because the severity of disease man-
ifestations is influenced by multiple variables, including
host genetic diversity, environmental factors and H. pylori
genetic heterogeneity [4].
Several genes, such as cagA, cagE, vacA, iceA, and
babA2, have been identified as markers for enhanced
pathogenicity of H. pylori. The cagA gene (cytotoxin-
associated gene) is a marker of the pathogenicity island
gene (cagPAI) presence. Infection with cagA-positive
strains is associated with a greater inflammatory response
and an increased risk of adverse clinical outcomes including
atrophic gastritis and gastric cancer [5, 6]. cagE is another
marker gene for cagPAI and has also been associated with a
more severe clinical outcome by stimulating the production
of several cytokines from infected epithelial cells [7].
The vacuolating cytotoxin gene (vacA) is present in all
H. pylori strains and comprises variable regions (signal-s,
middle-m and intermediate-i). VacA protein is a potent
cytotoxin that induces host cell vacuolation and, ultimately,
cell death [8]. There are different allele variations for this
gene, including for the signal (s1a, s1b, s1c, s2) and middle
region (m1 and m2). The mosaic combination of these
allelic types determines the level of cytotoxin produced
and, eventually, the histopathological modifications and
gastrointestinal manifestations. Strains with vacA s1 and
m1 alleles produce a large amount of toxin and epithelial
damage, whereas s2 and m2 genotypes produce little or no
toxin [8, 9]. Most vacA s1 strains are cagA-positive, thus
the two markers are closely related [9, 10].
The gene iceA (induced by contact with epithelium) has
two main allelic variants, iceA1 and iceA2. Expression of
iceA1 is upregulated on contact of H. pylori with human
epithelial cells and may be linked with peptic ulcer disease
[11].
The blood group antigen binding adhesin (BabA), a
protein encoded by the babA2 gene, binds to Lewis b
antigens and ABO antigen [12]. There are three alleles for
babA gene but only the babA2 gene product is functionally
active. The presence of this gene has been associated with
gastric cancer [13].
The distribution of H. pylori genotypes and its correla-
tion with histological modifications and disease outcomes
presents geographic differences. The present study aimed
to investigate whether there is any association of cagA,
cagE, vacA, iceA and babA2 genotypes with clinical pre-
sentation and gastric histological modifications in H. pylori
infected patients from the central region of Portugal.
Patients and Methods
Patients
In this single-center study, consecutive patients with non-
ulcer dyspepsia, peptic ulcer, iron-deficient anemia, indi-
cation for chronic therapy with proton pump inhibitors
(PPI) and/or first-degree relatives with gastric carcinoma
were prospectively considered for inclusion. All of them
had a positive 13C-urea breath test and indication for upper
endoscopy. Exclusion criteria were: age \18 years; preg-
nancy; lactating and/or fertile women who were not using
safe contraceptive methods; history of allergy/hypersensi-
tivity to any antibiotic or PPI; previous gastric malignancy
and/or gastric surgery; current use of anticoagulants;
marked thrombocytopenia; systemic severe disease (hepa-
tic, cardio-respiratory or renal disease; uncontrolled dia-
betes; active malignant diseases, coagulopathies); use of
antibiotics in the last 4 weeks; use of PPI in the last
2 weeks.
Study Design
All patients were submitted to upper endoscopy with four
biopsies in the antrum and four in the corpus, always
including a biopsy from incisura angularis. The first two
biopsies from the antrum and from the corpus were
immediately placed in independent containers of adequate
transport media—Portagerm pylori (bioMe´rieux Portugal,
Linda-A-Velha, Portugal)—at 4 C, and sent to microbi-
ology laboratory. Urease test and Gram staining of a smear
prepared from the biopsy specimen were performed to
confirm the presence of H. pylori. After manual grinding
with disposable material, the samples were distributed
directly in agar pylori (bioMe´rieux Portugal, Linda-A-
Velha, Portugal). Cultures were incubated for a minimum
of 72 h and a maximum of 10 days at 37 C under
microaerophilic conditions, produced with H2-CO2-
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generating packs (GENbox Microaer, bioMe´rieux Portugal,
Linda-A-Velha, Portugal). H. pylori isolates were identi-
fied by colony morphology, characteristic spiral morphol-
ogy on Gram staining, and positive catalase, urease and
oxidase tests.
The other biopsy specimens, for histological studies,
were fixed in 10 % formaldehyde. Formalin-fixed, paraffin-
embedded tissue, after cutting and adequate deparaffin-
ation, was then submitted to traditional staining with
hematoxylin ? eosin, modified Giemsa and Warthin-
Starry. Histological findings were described according to
the modified Sydney criteria [14]. Two different patholo-
gists, blinded to the genotype results, independently
reviewed all slides and evaluated the following histopa-
thological parameters: H. pylori density, chronic inflam-
mation (mononuclear infiltration), polymorphonuclear
activity (neutrophil activity), intestinal metaplasia and
glandular atrophy. These items were scored on an ordinal
scale: 0—absent; 1—mild; 2—moderate; 3—severe. Both
pathologists discussed discrepant results and a final grading
was established by consensus. For practical reasons, we
divided glandular atrophy and intestinal metaplasia in two
groups (0—absent; 1 to 3—present) and neutrophil activ-
ity, chronic inflammation and H. pylori colonization den-
sity also in two groups (0 ? 1—absent or mild; 2 ? 3—
moderate or severe). Gastritis stage was also assessed
according to the international Operative Link on Gastritis
Assessment (OLGA) and Operative Link on Intestinal
Metaplasia Assessment (OLGIM) [15–17].
Antrum and corpus samples were processed separately,
and we excluded patients with incomplete histological
results.
H. pylori Genotyping
DNA extraction from pure culture of H. pylori was per-
formed with a special extraction kit (QIAamp DNA Mini
Kits, QIAGEN, Izasa Portugal, Carnaxide, Portugal)
according to manufacturer’s instructions.
The cagA, cagE, vacA (s1a, s1b, s1c, m1, m2), iceA (A1,
A2), and babA2 genotypes were determined with real-time
PCR molecular technique by using specific primers selec-
ted from previously published works (Table 1) [9, 18–22].
For cagA, we used two sets of primers. A cagA-positive
status was defined when cagA gene was detected by at least
one of the two primer pairs.
PCR was performed in a volume of 20 ll containing
4.0 ll of LightCycler FastStart DNA MasterPLUS SYBR
Green I (Roche Diagnostics, Mannheim, Germany),
0.5 lM of each specific primers, 13.0 ll of H20 PCR grade
and 2.0 ll of DNA extract. An initial denaturation cycle at
95 C for 10 min was performed in all cases followed by
45 amplification cycles. Specific denaturation, annealing
and extension conditions for each set of primers are
expressed in Table 1. PCR products were checked on 2 %
agarose gels stained with ethidium bromide and transillu-
minated with UV light. Base-pair ladder size markers were
added (E-Gel Quantitative DNA Ladder, Invitrogen,
Carlsbad, USA), and positive and negative controls were
always included. Melting curves were also plotted auto-
matically and analyzed with the LightCycler software. By
comparing both results, it was possible to establish specific
melting temperatures to identify each gene. To avoid any
methodological error a different technician, blinded to
previous results, repeated all procedures. Positive and
negative controls were included.
Antrum and corpus specimens were processed sepa-
rately. If multiple strains were identified or if it was not
possible to determine cagA, cagE, vacA, iceA and/or
babA2 status the patient was excluded.
Statistical Analysis
The chi-square test and Fisher’s exact test were used to
assess the relationship between individual genotypes and
the presence of neutrophil activity, chronic inflammation,
colonization density, atrophy and intestinal metaplasia. The
same tests were performed to evaluate the relationship
between individual genotypes and clinical manifestations
and/or reason for H. pylori eradication. For multiple
comparisons involving the five genes, a Bonferroni cor-
rection was applied and only p values less than 0.01 were
considered statistically significant.
For each gene, a comparison of histopathological scores
was also performed with Mann–Whitney test. Paired
sample Wilcoxon test was used to compare antrum and
corpus scores.
The correlation of the ten histopathological phenotypes
with clinical variables was also performed with the
abovementioned tests, and the Bonferroni-adjusted p value
was 0.005.
Logistic regression model was obtained for each histo-
pathological phenotype using genotypes cagA, cagE, vacA,
iceA and babA2 as factors. Age, alcohol consumption,
tobacco consumption, local of residence and gender were
included as possible confounders. Results of logistic
regression were expressed as odds ratios (OR) with 95 %
confidence intervals (CI), and a p value less than 0.05 was
accepted as statistically significant.
Data were analyzed in SPSS version 20.0 (IBM, Illinois,
US).
Ethical Considerations
The study was approved by the ethical committee of our
Hospital and the Faculty of Medicine and performed in
76 Dig Dis Sci (2015) 60:74–85
123
accordance with the Declaration of Helsinki, the Interna-
tional Conference on Harmonisation Good Clinical Prac-
tice Guidelines, and applicable local laws and regulations.
Signed informed consent was obtained from each patient.
Results
Epidemiology and Histopathology
A total of 148 patients with infection by a single strain
of H. pylori and complete histological evaluation were
included. Their mean age was 43.5 ± 13.4 years (range
18–78) and 101 (68.2 %) had less than 50 years. Thirty-
eight (25.7 %) were male, 84 (56.8 %) lived in a rural
area, 33 (22.3 %) and 24 (16.2 %) had history of alco-
hol and tobacco consumption, respectively. These
patients were referred for H. pylori eradication for one
or more of the following reasons: non-ulcer dyspepsia—
65.5 %; chronic therapy with proton pump inhibitors—
24.3 %; iron-deficient anemia—20.3 %; first-degree rel-
atives with gastric cancer—18.9 %; peptic ulcer—8.1 %.
Gastritis classification according to updated Sydney
system is presented in Table 2. The average chronic
inflammation, neutrophil activity, glandular atrophy and
intestinal metaplasia scores in the antrum were signifi-
cantly higher than in the corpus. That did not happen
with H. pylori density scores. We found no cases of
epithelial dysplasia.
Older individuals (C50 years) presented higher degrees
of neutrophil activity for body (OR 2.68; 95 % CI
1.24–5.79) and antrum (OR 2.98; 95 %; CI 1.39–6.38),
atrophy for antrum (OR 5.13; 95 % CI 1.89–13.94) and
OLGA stages (levels I–III: C50 years—31.9 % versus
\50 years—6.9 %; p = 0.001). Residence in urban areas
was significantly associated with greater chronic inflam-
mation levels in the antrum (OR 3.04; 95 % CI 1.48–6.22).
There was no correlation of histopathological findings with
gender, history of former H. pylori eradication and alcohol/
tobacco consumption.
Table 1 Specific primers for detection of cagA, cagE, vacA, iceA and babA2 genes
Gene Primer Primer sequence (50–30) PCR conditions PCR product
(bp)
Reference
cagA A1 CCATGAATTTTTGATCCGTTCGG 95 C, 10 s; 62 C, 5 s; 72 C, 16 s 394 [18]
A2 GATAACAGGCAAGCTTTTGAGGGA
A3 ATGGGGAGTCATGATGGCATAGAACC 95 C, 10 s; 62 C, 5 s; 72 C, 16 s 717 [18]
A4 ATTAGGCAAATTAAAGACAGCCACC
cagE Forward AGACATGCAAAAAGGTAT 95 C, 10 s; 46 C, 5 s; 72 C, 37 s 900 [19]
Reverse CAATCTAGTGGGGTGGTA
vacA s1/s2 Forward ATGGAAATACAACAAACACAC 95 C, 10 s; 53 C, 5 s; 72 C, 12 s 259 (s1)
286 (s2)
[9, 20]
Reverse CTGCTTGAATGCGCCAAAC
vacA s1a Forward GTCAGCATCACACCGCAAC 95 C, 10 s; 56 C, 5 s; 72 C, 8 s 190 [21]
Reverse CTGCTTGAATGCGCCAAAC
vacA s1b Forward AGCGCCATACCGCAAGAG 95 C, 10 s; 56 C, 5 s; 72 C, 8 s 187 [21]
Reverse CTGCTTGAATGCGCCAAAC
vacA s1c Forward TTAGTTTCTCTCGCTTTAGTRGGGYT 95 C, 10 s; 60 C, 5 s; 72 C, 9 s 220 [19]
Reverse CTGCTTGAATGCGCCAAAC
vacA m1 Forward GGTCAAAATGCGGTCATGG 95 C, 10 s; 56 C, 5 s; 72 C, 12 s 290 [9, 22]
Reverse CCATTGGTACCTGTAGAAAC
vacA m2 Forward GGAGCCCCAGGAAACATTG 95 C, 10 s; 54 C, 5 s; 72 C, 15 s 352 [9, 22]
Reverse CATAACTAGCGCCTTGCAC
iceA1 Forward GTGTTTTTAACCAAAGTATC 95 C, 10 s; 51 C, 5 s; 72 C, 10 s 247 [20, 21]
Reverse CTATAGCCASTYTCTTTGCA
iceA2 Forward GTTGGGTATATCACAATTTAT 95 C, 10 s; 51 C, 5 s; 72 C, 14 s 229 or 334 [20, 21]
Reverse TTRCCCTATTTTCTAGTAGGT
babA2 Forward AATCCAAAAAGGAGAAAAAGTATGAAA 95 C, 10 s; 60 C, 5 s; 72 C, 34 s 832 [22]
Reverse TGTTAGTGATTTCGGTGTAGGACA
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Genotype Distribution
Genotype distribution according with real-time PCR is
presented in Table 3. Twenty-four of the 28 isolates
(85.7 %) with genotype vacA s1m1 were cagA positive,
and this relation was statistically significant (OR 25.30;
95 % CI 7.99–80.07). An inverse relationship was found
between cagA and vacA s2m2 (OR 0.06; 95 % CI
0.02–0.15). Thirteen of the 18 strains (72.2 %) positive for
babA2 also had cagA (OR 7.34; 95 % CI 2.44–22.12).
Correlation of Genotype with Clinical Manifestations,
Histopathology and Epidemiological Factors
Correlation between specific genotypes and clinical mani-
festations/indication for H. pylori eradication is presented
in Table 4.
When we compared epidemiological characteristics with
H. pylori genotypes, we found a significant association of
male sex with vacA m1 (OR 3.23; 95 % CI 1.39–7.14) and
vacA s1m1 (OR 3.33; 95 % CI 1.39–7.69).
An overview of genotype distribution and its relation-
ship with histopathological characteristics is presented in
Tables 5 and 6. Distribution according to OLGA and OL-
GIM staging systems is presented in Table 7. For OLGA,
there were no cases of patients in stages IV and the same
happened for OLGIM in stage III so we suppressed such
categories from the tables. Values for vacA m2 and iceA2
are the opposite ones from vacA m1 and iceA1, and we also
removed it from the tables. The same happened with vacA
s1c since we had only one positive isolate with this s1
subtype.
Combined genotype cagA positive ? vacA s1m1 was
more common in patients with peptic ulcer (OR 6.56; 95 %
CI 1.91–22.55), higher degrees of neutrophil activity in the
body (OR 3.96; 95 % CI 1.59–9.86) and antrum (OR 4.54;
95 % CI 1.47–14.05).
Genotype cagA positive ? vacA s1m1 ? babA2 posi-
tive occurred in 7 cases (4.7 %). It was significantly related
with higher degrees of H. pylori colonization in the body
(OR 22.20; 95 % CI 2.57–191.55) and antrum (OR 7.57;
95 % CI 1.41–40.78) and was more frequent in patients
with peptic ulcer (OR 11.00; 95 % CI 2.13–56.83).
In a logistic regression analysis including epidemio-
logical factors as potential confounders, we recognized the
subsequent significant associations: presence of intestinal
metaplasia in the antrum with cagA (OR 3.76; 95 % CI
1.26–11.24); higher levels of neutrophil activity in the
antrum with cagA (OR 2.58; 95 % CI 1.12–5.95);
Table 2 Classification of gastritis according to updated Sydney
system
Classification/grade Antrum (n) Corpus (n) p
Atrophy 0.008
0 128 (86.5 %) 144 (97.2 %)
1 19 (12.8 %) 2 (1.4 %)
2 1 (0.7 %) 1 (0.7 %)
3 0 (0 %) 1 (0.7 %)
Chronic inflammation <0.0001
0 0 (0 %) 15 (10.1 %)
1 101 (68.2 %) 120 (81.1 %)
2 47 (31.8 %) 11 (7.4 %)
3 0 (0 %) 2 (1.4 %)
Neutrophil activity <0.0001
0 3 (2.1 %) 28 (18.9 %)
1 60 (40.5 %) 83 (56.1 %)
2 65 (43.9 %) 31 (20.9 %)
3 20 (13.5 %) 6 (4.1 %)
Intestinal metaplasia 0.005
0 126 (85.1 %) 141 (95.2 %)
1 18 (12.1 %) 5 (3.4 %)
2 3 (2.1 %) 1 (0.7 %)
3 1 (0.7 %) 1 (0.7 %)
Density of H. pylori
colonization
0.571
0 2 (1.4 %) 1 (0.7 %)
1 106 (71.6 %) 111 (75 %)
2 30 (20.3 %) 28 (18.9 %)
3 10 (6.7 %) 8 (5.4 %)
Bold values are statistically significant
Table 3 Genotype distribution
for all 148 H. pylori isolates
Genotype n (%)
cagA positive 47 (31.8 %)
cagE positive 68 (45.9 %)
vacA s
vacA s1 66 (44.6 %)
vacA s1a 36 (24.3 %)
vacA s1b 29 (19.6 %)
vacA s1c 1 (0.7 %)
vacA s2 82 (55.4 %)
vacA m
vacA m1 31 (20.9 %)
vacA m2 117 (79.1 %)
vacA s ? m
vacA s1m1 28 (18.9 %)
vacA s1m2 38 (25.7 %)
vacA s2m1 3 (2 %)
vacA s2m2 79 (53.4 %)
iceA
iceA1 50 (33.8 %)
iceA2 98 (66.2 %)
babA2 18 (12.2 %)
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advanced levels of chronic inflammation in the body with
cagA (OR 4.61; 95 % CI 1.37–15.63); higher H. pylori
density scores in the body with babA2 (OR 7.46; 95 % CI
2.15–26.32).
Discussion
Although H pylori affects approximately 50 % of all
humans only a minority develop manifestations associated
with this infection. H pylori exceptional genetic variability
and intraspecies diversity contributes to this discrepancy
[23]. There is a geographic variability of H. pylori geno-
types [20, 24]. Patients infected with more virulent strains
have higher probabilities of developing complications [5].
Conclusions about the relation between H. pylori geno-
types and different clinical outcomes, if derived from a
single geographic region, may not be true for other geo-
graphic locations [19]. It is important to determine the most
prevalent genotypes in a specific region and to confirm
whether there is a correlation between putative virulence
genes and histological markers of severity. In areas of high
H. pylori infection prevalence, this information may
potentially help us to predict whether there is an increased
risk of gastric adenocarcinoma.
To our knowledge, this paper presents the largest char-
acterization to date of H. pylori isolates and associated
histopathological modifications collected from persons
living in the central region of Portugal. Our study popu-
lation is rather young but, even so, we demonstrated that
glandular atrophy, neutrophil activity, and OLGA stages
were significantly higher in older patients. Infection gen-
erally occurs during childhood and development of more
severe histopathological manifestations, such as intestinal
metaplasia and glandular atrophy, are linked to prolonged
infection and consequently to patients’ age [25, 26]. A
study performed in the northern part of the country also
revealed that patients with atrophic gastritis were signifi-
cantly older than the ones with no atrophy [5].
A remarkable result was the higher degrees of intestinal
metaplasia, glandular atrophy, neutrophil activity and
chronic inflammation in the antrum comparatively to the
body confirming that H. pylori infection in our patients
induces more histological changes in the antrum. Accord-
ing to the classification of chronic gastritis, antral pre-
dominant non-atrophic gastritis was the dominant pattern
in our cohort [17]. Most patients affected by this condition
have only a minimally increased risk of adenocarcinoma of
the distal stomach when compared with uninfected indi-
viduals [17, 27].
One of the most important virulence factors of H. pylori
is cagA that is present in about 60–70 % of the Western
strains and in more than 90 % of the East Asian ones [7,T
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28, 29]. In our study cagA genotype, albeit determined by
real-time PCR using two different sets of primers, was
identified in only 31.8 % of isolates. This is considerably
less than it was previously published for our country [5,
30]. There are different possible explanations for this
finding. First, cagA is more common in H. pylori infection
associated with peptic ulcer or gastric carcinoma. In our
study, 65.5 % of patients had non-ulcer dyspepsia and only
8.1 % had peptic ulcer. There were no cases of gastric
carcinoma. Van Doorn et al. [24] also presented a preva-
lence of cagA-positive strains of only 35.7 % in Egypt,
where most of the isolates were from non-ulcer patients.
Another possible explanation is that there is a national and
regional heterogeneity in distribution of H. pylori geno-
types and in the Central region of Portugal cagA negative
strains might be more common. Some authors already
stated that there are regional bacterial populations with
particular attributes making it difficult to establish uni-
versal virulence markers [31]. A recent study performed in
a region with one of the highest incidence and mortality
from gastric carcinoma in Spain and Western Europe
revealed a low prevalence of cagA-positive strains (47.7 %
of infected patients) [32]. Another recent study, from a
different Mediterranean country, also revealed a low
prevalence of cagA-positive strains (42.3 %) [33]. In a
Jordanian study, only 26.9 % of H. pylori isolates were
cagA positive [34]. However, albeit relatively rare in our
study population, cagA maintained a significant relation
with vacA s1m1, as already stated by multiple articles [10,
32, 33, 35]. Although cagA was found in only 31.8 % of
isolates, cagPAI was more frequent since cagE was present
in 45.9 %. A recent study, from Brazil, also reported higher
prevalence of cagE comparatively to cagA [31]. H. pylori
microevolution can determine loss of all or part of the
cagPAI [23]. In Japanese and French studies, cagE was
found to be a better marker for the presence of cagPAI than
cagA [36, 37]. We did not perform detection of cagPAI
empty site, and this is a limitation of our work. It is
interesting to notice that a recent study, in Portuguese
children, demonstrated a low prevalence (16.7 %) of cag-
PAI in patients with non-ulcer dyspepsia comparatively to
patients with peptic ulcer disease (75.4 %) [38].
In European and North American populations, cagA has
been associated with more severe disease such as gastric
mucosal atrophy, intestinal metaplasia and gastric cancer
[6, 10, 39, 40]. We think the same is valid for the central
Table 7 Relationship between
H. pylori genotype and OLGA/
OLGIM staging systems
Bold value is statistically
significant
NS (p [ 0.01)
Genotype (%) n OLGA p OLGIM p
0 I II III 0 I II IV
cagA ? 47 83 10.6 4.3 2.1 NS 68.1 21.3 8.5 2.1 0.001
- 101 86.1 13.9 0 0 88.1 11.9 0 0
cagE ? 68 85.3 14.7 0 0 NS 83.8 12.5 2.5 1.2 NS
- 80 85.1 11.2 2.5 1.2 79.4 17.6 3 0
vacA s1a ? 36 86.1 11.1 2.8 0 NS 72.3 19.4 8.3 0 NS
- 112 84.8 13.4 0.9 0.9 84.8 13.4 0.9 0.9
vacA s1b ? 29 75.9 17.3 3.4 3.4 NS 75.9 17.3 3.4 3.4 NS
- 119 87.4 11.8 0.8 0 83.2 14.3 2.5 0
vacA s2 ? 82 87.8 12.2 0 0 NS 87.8 12.2 0 0 NS
- 66 81.8 13.6 3.1 1.5 74.2 18.2 6.1 1.5
vacA m1 ? 31 87.1 9.7 3.2 0 NS 77.4 19.4 3.2 0 NS
- 115 84.6 13.6 0.9 0.9 82.8 13.7 2.6 0.9
vacA s1m1 ? 28 85.7 10.7 3.6 0 NS 75 21.4 3.6 0 NS
- 120 85.1 13.3 0.8 0.8 83.3 13.4 2.5 0.8
vacA s1m2 ? 38 79 15.8 2.6 2.6 NS 73.7 15.8 7.9 2.6 NS
- 110 87.3 11.8 0.9 0 84.5 14.5 1 0
vacA s2m1 ? 3 100 0 0 0 NS 100 0 0 0 NS
- 145 84.8 13.1 1.4 0.7 81.4 15.2 2.8 0.7
vacA s2m2 ? 79 87.3 12.7 0 0 NS 87.3 12.7 0 0 NS
- 69 82.6 13 2.9 1.4 75.4 17.4 5.8 1.4
iceA1 ? 50 80 14 4 2 NS 82 12 4 2 NS
- 98 87.8 12.2 0 0 81.6 16.3 2 0
babA2 ? 18 83.3 11.1 5.6 0 NS 72.2 16.7 11.1 0 NS
- 130 85.4 13.1 0.8 0.8 83.1 14.6 1.5 0.8
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region of Portugal since cagA-positive status was inde-
pendently associated with presence of intestinal metaplasia
in the antrum, higher degrees of neutrophil activity in the
antrum and chronic inflammation in the body as well as
higher OLGIM stages. So, this genotype, although rare in
our population, was the most frequently related with wor-
risome histopathological features.
Gene cagE is also within the cag PAI and has been
associated with a more severe clinical outcome [7]. In the
central region of Portugal, cagE is more prevalent than
cagA and has no relation with clinical presentation or
gastric histopathology. In our population, this marker of
cagPAI, although more frequent, is clearly less pathogenic
than the cagA. Proenc¸a Modena et al. [31] also found no
correlation of cagE with disease outcomes.
There are clear geographic differences in the distribution
of both vacA s and m subtypes [24, 33]. The H. pylori vacA
s1m1 genotype is the most common in American, Euro-
pean and East Asian countries [24, 29, 41–43]. The vacA
s2m2 genotype is apparently less common and another
study in Portugal, performed in patients submitted to a
screening program, revealed a prevalence of 29.7 % for
such allele combination (42.9 % if multiple vacA geno-
types were excluded). The vacA s2m2 prevalence found in
our study is among the highest reported [24]. This was
expected given the high prevalence of cagA negative
strains and the association of such genetic profile with vacA
s2 and vacA m2 [24]. This reflects the presence of less
virulent strains in the central region of Portugal. However,
we cannot forget that we have few cases with peptic ulcer
disease and none with gastric cancer. A selection bias
cannot be completely excluded, and this is a limitation of
our work. Even so, it is interesting to notice that Boukhris
et al. [33] identified a higher prevalence (59.2 %) of vacA
s2m2 genotype in 145 Moroccan isolates with a single
association of vacA s and m alleles. The same happened in
another study in our neighbour, Spain, also with vacA s2m2
being the dominant genotype [32].
Mosaicism vacA s2m1 was detected in only 3 patients,
confirming that this genotype is very rare [9, 10, 24]. Van
Doorn et al. established that in the Iberian Peninsula sub-
type s1b was the dominant one [24, 44, 45]. By the con-
trary, our study demonstrates that in the central region s2 is
the more common allele followed by s1a. It is known that
vacA s1m1 strains determine higher levels of inflammation
in the gastric mucosa and both vacA s1m1 and s1m2 strains
may be disease-associated but patients with gastric cancer
usually have the s1m1 type [5, 10, 28, 39, 44, 46]. In our
population, we found no correlations of vacA genotypes
with gastric histopathological modifications. The last
published data about gastric carcinoma epidemiology in
Portugal revealed a low incidence rate in the central region
comparatively to the south and north [47]. Predominance of
less virulent strains in this part of the country could par-
tially explain such differences. However, the relatively
small number of isolates with s1m1 and s1m2 and the
absence of patients with gastric carcinoma cannot allow us
to confirm or deny this association. A larger, epidemio-
logical population-based study would be necessary to
clarify these doubts.
We identified an isolate with subtype s1c. This allelic
variant is essentially detected in East Asian patients but
some cases were already described in Westerners [7, 40,
41, 48].
The m1 allele is relatively rare compared with m2. This
is also the opposite of what was previously established for
the Iberian Peninsula but similar to the results presented
more recently by Gonza´lez et al. for a specific Spanish
region [24, 32].
The iceA1 allelic variant of iceA may be linked with
the development of peptic ulcers since iceA1 positive
strains produce more proinflammatory factor IL-8 [7,
49]. In our study, population iceA2 subtype was the
dominant one, as previously stated for Western patients
[7, 11, 20, 22]. The relationship of iceA with gastric
histopathology and clinical presentation is also very
different from study to study [13, 20, 45]. In our work,
we did not find any specific association of iceA allelic
variants with pathological or clinical phenotype. Another
study, involving patients from the northern region of the
country, also failed to found a relation between the iceA
allelic variants and clinical outcome of H. pylori infec-
tion [45].
The babA2 gene has been strongly associated with cagA
and vacA s1 in some populations [12]. Prevalence of babA2
positive strains is very heterogeneous and can be as high as
92.3 % [7, 13, 22]. This genotype can determine a higher
risk of ulcer and gastric adenocarcinoma but this is con-
troversial [7]. In our study, babA2 was very rare and only
associated with higher H. pylori density scores in the
gastric body. To confirm the real prevalence of babA, some
authors recommend immunoblot as well as the use of
several primer pairs by PCR because of possible sequence
variations [50, 51].
Strains with vacA s1m1 as well as genotype combina-
tions cagA positive ? vacA s1m1 and cagA positive ?
vacA s1m1 ? babA2 were associated with peptic ulcer.
The correlation of such clinical manifestation with these
genotypes is consistent with earlier studies [35, 41, 52].
This is explained by the higher virulence and mucosal
injury determined by such strains. On the contrary, the less
virulent H. pylori genotype vacA s2m2 was more common
in asymptomatic patients, with iron-deficient anemia.
Traditionally, less aggressive vacA s2m2 strains are
more common in patients with functional dyspepsia
although some studies reported the opposite correlation
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[53, 54]. In our study, no significant association with this
clinical manifestation was detected.
A major limitation of our work is that we studied only a
few genes and, as we know, the average size of an H. pylori
genome is estimated at 1.62 Mb consisting of 1,590 open-
reading frames encoding 1,532 proteins [55]. Probably, in a
near future, with increased availability of next-generation
sequencing, multiple H. pylori complete genomes will be
studied and we will discover and/or relate other genes and
respective proteins as major factors for specific clinical
manifestations of H. pylori infection as well as histological
parameters of H. pylori related gastritis.
Another limitation was the relatively low number of
patients with specific histopathological modifications (e.g.,
corpus glandular atrophy) and clinical manifestations. We
had only 12 patients with peptic ulcer and none with gastric
cancer. We even had a large number of patients referred for
H. pylori eradication only because they had first-degree
relatives with gastric cancer. Our hospital is a tertiary-
referral center, and we included only patients from ambu-
latory clinical practice. Obviously, the ones with compli-
cated peptic ulcers or gastric cancers are referred for
admission and specific treatment. A population-based study
could, eventually, overcome this problem.
Genetic factors for infected host can be a very important
determinant of infection result. Not including this variable
in our work is a major restraint.
H. pylori induces chronic gastritis in virtually all
infected patients [26, 32]. However, gastritis and preneo-
plastic lesions such as glandular atrophy and intestinal
metaplasia also occur in uninfected patients. Our work did
not involve H. pylori negative controls and so we do not
know the real correlation of gastric histopathological
modifications with H. pylori infection.
Finally, most authors that study this problem consider
all patients, including the ones with multiple H. pylori
genotypes. Previous studies in Portugal revealed a high
prevalence of patients harboring multiple H. pylori strains
[5, 21, 45]. However, for correlation of H. pylori genotypes
with gastric histopathology, most authors exclude patients
with multiple isolates. In our opinion, this strategy can be
somehow confuse and difficult to interpret so we decided to
consider only patients with single H. pylori genotypes.
Conclusions
Higher scores of intestinal metaplasia and gastric mucosa
inflammation are detected in patients infected by cagA-
positive H. pylori isolates confirming the increased viru-
lence of such strains and the potentially worst outcomes in
these cases. IceA2 allelic variant is the predominant one
and has no correlation with disease phenotype. Gene babA2
is rare and associated with higher H. pylori colonization
density in the corpus.
Patients with peptic ulcer are frequently infected by H.
pylori with the vacA s1m1 allelic variant or the combina-
tion cagA ? vacA s1m1 and cagA positive ? vacA
s1m1 ? babA2.
In the central region of Portugal, there is a predomi-
nance of less virulent strains while maintaining the usual
correlation with gastric histopathology. This implies low
prevalence of gastric atrophy and/or intestinal metaplasia
and hypothetically, of gastric adenocarcinoma. Our results,
compared with earlier published ones, from other regions,
demonstrate that, in the same country, H. pylori genotype
may have a marked regional variability.
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